3-[[2-(1-Naphtylacetyl)hydrazono]methyl]rifamycin

Modify Date: 2025-09-05 15:12:33

3-[[2-(1-Naphtylacetyl)hydrazono]methyl]rifamycin Structure
3-[[2-(1-Naphtylacetyl)hydrazono]methyl]rifamycin structure
Common Name 3-[[2-(1-Naphtylacetyl)hydrazono]methyl]rifamycin
CAS Number 51707-04-1 Molecular Weight 908.00000
Density 1.4±0.1 g/cm3 Boiling Point 1030.6±65.0 °C at 760 mmHg
Molecular Formula C50H57N3O13 Melting Point N/A
MSDS N/A Flash Point 577.1±34.3 °C

 Names

Name (9E,19E,26E)-2,15,17,29-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{[2-(1-naphthylacetyl)hydrazino]methylene}-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 1030.6±65.0 °C at 760 mmHg
Molecular Formula C50H57N3O13
Molecular Weight 908.00000
Flash Point 577.1±34.3 °C
Exact Mass 907.38900
PSA 246.26000
LogP 5.91
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.656

 Synonyms

1-Naphthaleneacetic acid, 2-[(E)-[(14E,24E)-21-(acetyloxy)-1,9-dihydro-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-8(2H)-ylidene]methyl]hydrazide
(9E,19E,26E)-2,15,17,29-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{[2-(1-naphthylacetyl)hydrazino]methylene}-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triaconta- 
1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

3-[[2-(1-Naphtylacetyl)hydrazono]methyl]rifamycin suppliers

3-[[2-(1-Naphtylacetyl)hydrazono]methyl]rifamycin price

Related Compounds: More...
3-[(2-pyrrolidin-1-yl-ethoxyimino)-methyl]-rifamycin
22912-88-5
3-[[[2-(4-Methyl-1-piperazinyl)ethoxy]imino]methyl]rifamycin
22912-78-3
3-[2-(2,4-dinitrophenyl)carbonohydrazonoyl]-1,2-benzenediol
1453261-85-2
3-[2-(diethylamino)ethyl]-1-methyl-3-phenylpyrrolidine-2,5-dione,hydrochloride
100786-96-7
3-[2-(1,3-diethoxy-1,3-dioxopropan-2-ylidene)hydrazinyl]benzoic acid
59064-20-9
3-(2-methoxyphenyl)-1-methyl-1-phenylurea
59849-57-9
3-[2-carboxyethyl-(3-methoxy-3-oxopropyl)phosphanyl]propanoic acid
820248-63-3
Rifamycin, 3-[[(2-hydroxyethyl)hydrazono]methylenyl]-
13292-33-6
STK899704
1578247-29-6
(Z)-2-(4-(4-bromophenyl)thiazol-2-yl)-3-((2-methyl-4-nitrophenyl)amino)acrylonitrile
374548-51-3
(Z)-ethyl 2-((2-cyano-2-(4-(3,4-dimethylphenyl)thiazol-2-yl)vinyl)amino)-4-methyl-5-(phenylcarbamoyl)thiophene-3-carboxylate
773865-37-5
(E)-3-(benzo[d][1,3]dioxol-5-yl)-5-((5-(2-fluorophenyl)furan-2-yl)methylene)-2-thioxothiazolidin-4-one
900134-88-5
(E)-4-(5-((5-(2-fluorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)-2-hydroxybenzoic acid
900134-92-1
(E)-4-(5-((5-(4-fluorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid
893694-63-8
(E)-3-(5-((5-(4-fluorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid
340752-32-1
(Z)-N-(4,6-dimethylbenzo[d]thiazol-2-yl)-3-(5-(4-methoxybenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanamide
900135-01-5
(Z)-3-(5-(2-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(1-hydroxy-3-phenylpropan-2-yl)propanamide
900135-02-6
(Z)-3-(5-(2-chlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(2-(3,4-dihydroxyphenyl)-2-oxoethyl)-N-methylpropanamide
900135-03-7
3-[(5Z)-5-(2-chlorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-[2-(1H-indol-3-yl)ethyl]propanamide
900135-05-9